Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agents (vol 151, 107665, 2024)

被引：0

作者：

Cheng, Yao ^{[1
]}

Jones, John Patrick ^{[1
]}

Yu, Tsz Tin ^{[1
]}

Olzomer, Ellen M. ^{[2
]}

Su, Jacky ^{[1
]}

Katen, Alice ^{[1
]}

Black, David StC ^{[1
]}

Hart-Smith, Gene ^{[3
]}

Childress, Elizabeth S. ^{[4
,5
]}

Beretta, Martina ^{[2
]}

Wilkins, Marc R. ^{[2
]}

Mateos, Isabel A. ^{[2
]}

Santos, Webster L. ^{[4
,5
]}

Hoehn, Kyle L. ^{[2
]}

Byrne, Frances L. ^{[2
]}

Kumar, Naresh ^{[1
]}

机构：

[1] Univ New South Wales, Sch Chem, Sydney, NSW 2052, Australia

[2] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia

[3] Macquarie Univ, Australian Proteome Anal Facil, Macquarie Pk, NSW 2109, Australia

[4] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA

[5] Virginia Tech, VT Ctr Drug Discovery, Blacksburg, VA 24061 USA

来源：

BIOORGANIC CHEMISTRY | 2024年 / 151卷

关键词：

D O I：

10.1016/j.bioorg.2024.107725

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：1

共 50 条

[1] Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agents
Cheng, Yao
Jones, John Patrick
Yu, Tsz Tin
Olzomer, Ellen M.
Su, Jacky
Katen, Alice
Black, David StC
Hart-Smith, Gene
Childress, Elizabeth S.
Wilkins, Marc R.
Mateos, Isabel A.
Santos, Webster L.
Hoehn, Kyle L.
Byrne, Frances L.
Kumar, Naresh
BIOORGANIC CHEMISTRY, 2024, 151
[2] Design, synthesis and biological evaluation of dual HDAC and VEGFR inhibitors as multitargeted anticancer agents
Xue, Xia
Zhang, Yingjie
Liao, Yongxiang
Sun, Deqing
Li, Lina
Liu, Ying
Wang, Yongjie
Jiang, Wen
Zhang, Jian
Luan, Yun
Zhao, Xiaogang
INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 10 - 20
[3] Design, synthesis and biological evaluation of dual HDAC and VEGFR inhibitors as multitargeted anticancer agents
Xia Xue
Yingjie Zhang
Yongxiang Liao
Deqing Sun
Lina Li
Ying Liu
Yongjie Wang
Wen Jiang
Jian Zhang
Yun Luan
Xiaogang Zhao
Investigational New Drugs, 2022, 40 : 10 - 20
[4] Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
Abadi, Ashraf H.
Ibrahim, Tamer M.
Abouzid, Khaled M.
Lehmann, Jochen
Tinsley, Heather N.
Gary, Bernard D.
Piazza, Gary A.
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (16) : 5974 - 5982
[5] Design, synthesis and biological evaluation of rhein derivatives as anticancer agents
Huang, Junkai
Zhang, Zhuo
Huang, Peng
He, Liqin
Ling, Yong
MEDCHEMCOMM, 2016, 7 (09) : 1812 - 1818
[6] Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents
D'Andrea, Felicia
Vagelli, Giulia
Granchi, Carlotta
Guazzelli, Lorenzo
Tuccinardi, Tiziano
Poli, Giulio
Iacopini, Dalila
Minutolo, Filippo
Di Bussolo, Valeria
MOLECULES, 2019, 24 (19):
[7] Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors
Ramkaran, Ramkaran
Rawal, Ravindra K. K.
Gupta, Praveen K. K.
Kumar, Bhupinder
Bhatia, Rohit
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023, 21 (01) : 17 - 28
[8] Design, synthesis, biological evaluation, and molecular docking of novel quinazolinone EGFR inhibitors as targeted anticancer agents
Nofal, Zinab M.
Amin, Kamelia M.
Mohamed, Hanaa S.
El-Kerdawy, Ahmed M.
Aly, Magdy S.
Habib, Basma S.
Sarhan, Alaadin E.
SYNTHETIC COMMUNICATIONS, 2022, 52 (18) : 1805 - 1824
[9] Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents
Abdelazeem, Ahmed H.
Gouda, Ahmed M.
Omar, Hany A.
Tolba, Mai F.
BIOORGANIC CHEMISTRY, 2014, 57 : 132 - 141
[10] Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
Lu, Yan
Chen, Jianjun
Wang, Jin
Li, Chien-Ming
Ahn, Sunjoo
Barrett, Christina M.
Dalton, James T.
Li, Wei
Miller, Duane D.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (17) : 7355 - 7366

← 1 2 3 4 5 →